跳至主要内容
临床试验/EUCTR2021-000413-17-SE
EUCTR2021-000413-17-SE进行中(未招募)1 期

COVERS (COVID-Vaccination Efficiency Risk and Safety Study)- an open trial for follow-up of efficacy, risk and safety in persons who have been vaccinated against SARS-CoV-2 in Region Skåne with vaccines approved in Sweden

Region Skåne - Kliniska Studier Sverige, Forum Söder0 个研究点目标入组 4,000 人开始时间: 2021年2月15日最近更新:
适应症

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
4,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • 1. To be included, the person must have received the COVID-19 vaccine.
  • 2. To be included, the person must, in addition to vaccination against COVID-19, also have
  • a) signed by EPM approved participant information
  • b) reached the age of 18.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 3000
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1000

排除标准

  • Subjects below the age of 18 are excluded

研究者

发起方
Region Skåne - Kliniska Studier Sverige, Forum Söder

相似试验